Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Crossed Above 20 DMA | Bullish | -7.50% | |
| Crossed Above 50 DMA | Bullish | -7.50% | |
| 20 DMA Resistance | Bearish | 4.57% | |
| Fell Below 20 DMA | Bearish | 2.12% | |
| Outside Day | Range Expansion | 2.12% | |
| NR7 | Range Contraction | -2.83% | |
| Narrow Range Bar | Range Contraction | -2.83% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| Rose Above Previous Day's High | about 18 hours ago |
| Up 3% | about 18 hours ago |
| Fell Below 50 DMA | about 18 hours ago |
| Down 2 % | about 18 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.04 |
| 52 Week Low | 4.22 |
| Average Volume | 41,224 |
| 200-Day Moving Average | 6.44 |
| 50-Day Moving Average | 5.05 |
| 20-Day Moving Average | 4.75 |
| 10-Day Moving Average | 5.00 |
| Average True Range | 0.39 |
| RSI (14) | 48.45 |
| ADX | 23.24 |
| +DI | 23.61 |
| -DI | 15.08 |
| Chandelier Exit (Long, 3 ATRs) | 4.39 |
| Chandelier Exit (Short, 3 ATRs) | 5.39 |
| Upper Bollinger Bands | 5.40 |
| Lower Bollinger Band | 4.09 |
| Percent B (%b) | 0.55 |
| BandWidth | 27.56 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.08 |
| MACD Histogram | 0.0464 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.67 | ||||
| Resistance 3 (R3) | 5.77 | 5.58 | 5.53 | ||
| Resistance 2 (R2) | 5.58 | 5.36 | 5.53 | 5.48 | |
| Resistance 1 (R1) | 5.19 | 5.22 | 5.10 | 5.10 | 5.43 |
| Pivot Point | 5.00 | 5.00 | 4.95 | 4.95 | 5.00 |
| Support 1 (S1) | 4.62 | 4.78 | 4.52 | 4.52 | 4.19 |
| Support 2 (S2) | 4.43 | 4.65 | 4.38 | 4.14 | |
| Support 3 (S3) | 4.04 | 4.43 | 4.09 | ||
| Support 4 (S4) | 3.95 |
